These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21718968)

  • 1. Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa.
    Gérard N; Pieters G; Goffin K; Bormans G; Van Laere K
    Biol Psychiatry; 2011 Oct; 70(8):777-784. PubMed ID: 21718968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study.
    Ceccarini J; Weltens N; Ly HG; Tack J; Van Oudenhove L; Van Laere K
    Transl Psychiatry; 2016 Jul; 6(7):e853. PubMed ID: 27404285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders.
    Frieling H; Albrecht H; Jedtberg S; Gozner A; Lenz B; Wilhelm J; Hillemacher T; de Zwaan M; Kornhuber J; Bleich S
    Psychoneuroendocrinology; 2009 May; 34(4):620-4. PubMed ID: 19046818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.
    Bailer UF; Frank GK; Price JC; Meltzer CC; Becker C; Mathis CA; Wagner A; Barbarich-Marsteller NC; Bloss CS; Putnam K; Schork NJ; Gamst A; Kaye WH
    Psychiatry Res; 2013 Feb; 211(2):160-8. PubMed ID: 23154100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.
    Monteleone P; Bifulco M; Di Filippo C; Gazzerro P; Canestrelli B; Monteleone F; Proto MC; Di Genio M; Grimaldi C; Maj M
    Genes Brain Behav; 2009 Oct; 8(7):728-32. PubMed ID: 19659925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.
    Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Weissfeld L; Mathis CA; Drevets WC; Wagner A; Hoge J; Ziolko SK; McConaha CW; Kaye WH
    Arch Gen Psychiatry; 2005 Sep; 62(9):1032-41. PubMed ID: 16143735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the neural circuitry of appetitive regulation in eating disorders.
    Kaye WH; Bailer UF
    Biol Psychiatry; 2011 Oct; 70(8):704-705. PubMed ID: 21967986
    [No Abstract]   [Full Text] [Related]  

  • 8. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET.
    Van Laere K; Goffin K; Casteels C; Dupont P; Mortelmans L; de Hoon J; Bormans G
    Neuroimage; 2008 Feb; 39(4):1533-41. PubMed ID: 18077184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of type 1 cannabinoid receptor availability in the human brain to novelty-seeking temperament.
    Van Laere K; Goffin K; Bormans G; Casteels C; Mortelmans L; de Hoon J; Grachev I; Vandenbulcke M; Pieters G
    Arch Gen Psychiatry; 2009 Feb; 66(2):196-204. PubMed ID: 19188542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam.
    Goffin K; Bormans G; Casteels C; Bosier B; Lambert DM; Grachev ID; Van Paesschen W; Van Laere K
    Neuropharmacology; 2008 Jun; 54(7):1103-6. PubMed ID: 18423778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's disease.
    Ceccarini J; Casteels C; Ahmad R; Crabbé M; Van de Vliet L; Vanhaute H; Vandenbulcke M; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2348-2357. PubMed ID: 31342135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interictal type 1 cannabinoid receptor binding is increased in female migraine patients.
    Van der Schueren BJ; Van Laere K; Gérard N; Bormans G; De Hoon JN
    Headache; 2012 Mar; 52(3):433-40. PubMed ID: 22077199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa.
    Casteels C; Gérard N; van Kuyck K; Pottel L; Nuttin B; Bormans G; Van Laere K
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):308-21. PubMed ID: 24006151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
    Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH
    Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of chronic nicotine administration on cerebral type 1 cannabinoid receptor binding: an in vivo micro-PET study in the rat using [18F]MK-9470.
    Gérard N; Ceccarini J; Bormans G; Vanbilloen B; Casteels C; Goffin K; Bosier B; Lambert DM; Van Laere K
    J Mol Neurosci; 2010 Oct; 42(2):162-7. PubMed ID: 20182818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence.
    Ceccarini J; Hompes T; Verhaeghen A; Casteels C; Peuskens H; Bormans G; Claes S; Van Laere K
    J Neurosci; 2014 Feb; 34(8):2822-31. PubMed ID: 24553924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex difference in brain CB1 receptor availability in man.
    Laurikainen H; Tuominen L; Tikka M; Merisaari H; Armio RL; Sormunen E; Borgan F; Veronese M; Howes O; Haaparanta-Solin M; Solin O; Hietala J;
    Neuroimage; 2019 Jan; 184():834-842. PubMed ID: 30296558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
    Burns HD; Van Laere K; Sanabria-Bohórquez S; Hamill TG; Bormans G; Eng WS; Gibson R; Ryan C; Connolly B; Patel S; Krause S; Vanko A; Van Hecken A; Dupont P; De Lepeleire I; Rothenberg P; Stoch SA; Cote J; Hagmann WK; Jewell JP; Lin LS; Liu P; Goulet MT; Gottesdiener K; Wagner JA; de Hoon J; Mortelmans L; Fong TM; Hargreaves RJ
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9800-5. PubMed ID: 17535893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.
    Ceccarini J; Kuepper R; Kemels D; van Os J; Henquet C; Van Laere K
    Addict Biol; 2015 Mar; 20(2):357-67. PubMed ID: 24373053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.
    Berner LA; Brown TA; Lavender JM; Lopez E; Wierenga CE; Kaye WH
    Mol Cell Endocrinol; 2019 Nov; 497():110320. PubMed ID: 30395874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.